Defining the cancer master switch

Courtney J. Balentine, David H. Berger, Shi He Liu, Changyi Chen, John Nemunaitis, F. Charles Brunicardi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Recent research has focused on signaling cascades and their interactions yielding considerable insight into which genetic pathways are targeted and how they tend to be altered in tumors. Therapeutic interventions now can be designed based on the knowledge of pathways vital to tumor growth and survival. These critical targets for intervention, master switches for cancer, are termed so because the tumor attempts to "flip the switch" in a way that promotes its survival, whereas molecular therapy aims to "switch off" signals important for tumor-related processes. Methods: Literature review. Conclusions: Defining useful targets for therapy depends on identifying pathways that are crucial for tumor growth, survival, and metastasis. Because not all signaling cascades are created equal, selecting master switches or targets for intervention needs to be done in a systematic fashion. This discussion proposes a set of criteria to define what it means to be a cancer master switch and provides examples to illustrate their application.

Original languageEnglish (US)
Pages (from-to)1738-1745
Number of pages8
JournalWorld Journal of Surgery
Volume35
Issue number8
DOIs
StatePublished - Aug 1 2011
Externally publishedYes

Fingerprint

Neoplasms
Growth
Therapeutics
Neoplasm Metastasis
Research

ASJC Scopus subject areas

  • Surgery

Cite this

Balentine, C. J., Berger, D. H., Liu, S. H., Chen, C., Nemunaitis, J., & Brunicardi, F. C. (2011). Defining the cancer master switch. World Journal of Surgery, 35(8), 1738-1745. https://doi.org/10.1007/s00268-010-0941-2

Defining the cancer master switch. / Balentine, Courtney J.; Berger, David H.; Liu, Shi He; Chen, Changyi; Nemunaitis, John; Brunicardi, F. Charles.

In: World Journal of Surgery, Vol. 35, No. 8, 01.08.2011, p. 1738-1745.

Research output: Contribution to journalArticle

Balentine, CJ, Berger, DH, Liu, SH, Chen, C, Nemunaitis, J & Brunicardi, FC 2011, 'Defining the cancer master switch', World Journal of Surgery, vol. 35, no. 8, pp. 1738-1745. https://doi.org/10.1007/s00268-010-0941-2
Balentine CJ, Berger DH, Liu SH, Chen C, Nemunaitis J, Brunicardi FC. Defining the cancer master switch. World Journal of Surgery. 2011 Aug 1;35(8):1738-1745. https://doi.org/10.1007/s00268-010-0941-2
Balentine, Courtney J. ; Berger, David H. ; Liu, Shi He ; Chen, Changyi ; Nemunaitis, John ; Brunicardi, F. Charles. / Defining the cancer master switch. In: World Journal of Surgery. 2011 ; Vol. 35, No. 8. pp. 1738-1745.
@article{34f9c793b79246c8b895c6b5b80a036a,
title = "Defining the cancer master switch",
abstract = "Background: Recent research has focused on signaling cascades and their interactions yielding considerable insight into which genetic pathways are targeted and how they tend to be altered in tumors. Therapeutic interventions now can be designed based on the knowledge of pathways vital to tumor growth and survival. These critical targets for intervention, master switches for cancer, are termed so because the tumor attempts to {"}flip the switch{"} in a way that promotes its survival, whereas molecular therapy aims to {"}switch off{"} signals important for tumor-related processes. Methods: Literature review. Conclusions: Defining useful targets for therapy depends on identifying pathways that are crucial for tumor growth, survival, and metastasis. Because not all signaling cascades are created equal, selecting master switches or targets for intervention needs to be done in a systematic fashion. This discussion proposes a set of criteria to define what it means to be a cancer master switch and provides examples to illustrate their application.",
author = "Balentine, {Courtney J.} and Berger, {David H.} and Liu, {Shi He} and Changyi Chen and John Nemunaitis and Brunicardi, {F. Charles}",
year = "2011",
month = "8",
day = "1",
doi = "10.1007/s00268-010-0941-2",
language = "English (US)",
volume = "35",
pages = "1738--1745",
journal = "Presentations from the 9th Annual Electric Utilities Environmental Conference",
issn = "0364-2313",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Defining the cancer master switch

AU - Balentine, Courtney J.

AU - Berger, David H.

AU - Liu, Shi He

AU - Chen, Changyi

AU - Nemunaitis, John

AU - Brunicardi, F. Charles

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Background: Recent research has focused on signaling cascades and their interactions yielding considerable insight into which genetic pathways are targeted and how they tend to be altered in tumors. Therapeutic interventions now can be designed based on the knowledge of pathways vital to tumor growth and survival. These critical targets for intervention, master switches for cancer, are termed so because the tumor attempts to "flip the switch" in a way that promotes its survival, whereas molecular therapy aims to "switch off" signals important for tumor-related processes. Methods: Literature review. Conclusions: Defining useful targets for therapy depends on identifying pathways that are crucial for tumor growth, survival, and metastasis. Because not all signaling cascades are created equal, selecting master switches or targets for intervention needs to be done in a systematic fashion. This discussion proposes a set of criteria to define what it means to be a cancer master switch and provides examples to illustrate their application.

AB - Background: Recent research has focused on signaling cascades and their interactions yielding considerable insight into which genetic pathways are targeted and how they tend to be altered in tumors. Therapeutic interventions now can be designed based on the knowledge of pathways vital to tumor growth and survival. These critical targets for intervention, master switches for cancer, are termed so because the tumor attempts to "flip the switch" in a way that promotes its survival, whereas molecular therapy aims to "switch off" signals important for tumor-related processes. Methods: Literature review. Conclusions: Defining useful targets for therapy depends on identifying pathways that are crucial for tumor growth, survival, and metastasis. Because not all signaling cascades are created equal, selecting master switches or targets for intervention needs to be done in a systematic fashion. This discussion proposes a set of criteria to define what it means to be a cancer master switch and provides examples to illustrate their application.

UR - http://www.scopus.com/inward/record.url?scp=80051556814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051556814&partnerID=8YFLogxK

U2 - 10.1007/s00268-010-0941-2

DO - 10.1007/s00268-010-0941-2

M3 - Article

C2 - 21286716

AN - SCOPUS:80051556814

VL - 35

SP - 1738

EP - 1745

JO - Presentations from the 9th Annual Electric Utilities Environmental Conference

JF - Presentations from the 9th Annual Electric Utilities Environmental Conference

SN - 0364-2313

IS - 8

ER -